4//SEC Filing
CORTEX PHARMACEUTICALS INC/DE/ 4
Accession 0001363763-15-000013
CIK 0000849636operating
Filed
Aug 19, 8:00 PM ET
Accepted
Aug 20, 5:31 PM ET
Size
6.8 KB
Accession
0001363763-15-000013
Insider Transaction Report
Form 4
Purcell Richard David Jr.
SVP - Research & Development
Transactions
- Award
Common Stock Options (to purchase shares of Common Stock)
2015-08-18+3,000,000→ 3,000,000 totalExercise: $0.02Exp: 2022-08-18→ Common Stock (3,000,000 underlying)
Holdings
- 2,000,000
Common Stock Options (to purchase shares of Common Stock)
Exercise: $0.03Exp: 2022-06-30→ Common Stock (2,000,000 underlying)
Footnotes (2)
- [F1]These Common Stock Options vest in four equal installments: 25 percent on December 31, 2015, 25 percent on March 31, 2016, 25 percent on June 30, 2016, and 25 percent on September 30, 2016.
- [F2]The Common Stock Options vest in three installments: 50 percent on June 30, 2015, 25 percent on September 30, 2015, and 25 percent on December 31, 2015.
Documents
Issuer
CORTEX PHARMACEUTICALS INC/DE/
CIK 0000849636
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000849636
Filing Metadata
- Form type
- 4
- Filed
- Aug 19, 8:00 PM ET
- Accepted
- Aug 20, 5:31 PM ET
- Size
- 6.8 KB